Clinical Trials

Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 2/Phase 3
  • Intervention Type: Drug
  • Participants: 42
  • Start Date: February 1, 2021
Evaluating the Therapeutic Efficacy of Filgrastim in Severe Bullous Drug Eruptions (Lyell and Stevens-Johnson Syndromes)
Search for trials
Clinical Trial
  • Status: Not yet recruiting
  • Intervention Type: Drug
  • Participants: 750
  • Start Date: January 1, 2021
A Prospective Multicenter Cohort Study Assessing Outcomes in Stevens Johnsons Syndrome and Toxic Epidermal Necrolysis
Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 1/Phase 2
  • Intervention Type: Drug
  • Participants: 15
  • Start Date: January 2021
Mesenchymal Stromal Cells Treatment in Lyell Syndrome: A Pilot Phase 1-2 Open Trial
Clinical Trial
  • Status: Recruiting
  • Intervention Type: Other
  • Participants: 65
  • Start Date: October 2, 2019
Association of Cytokines With the Development of Complications in Burn and Toxic Epidermal Necrolysis (TENS) Patients
Clinical Trial
  • Status: Not yet recruiting
  • Phase: N/A
  • Intervention Type: Device
  • Participants: 10
  • Start Date: September 2019
Histologic Evaluation Comparing Power Settings in Radiofrequency Ablation on Eyelash Follicles
Clinical Trial
  • Status: Recruiting
  • Participants: 500
  • Start Date: September 26, 2018
Adverse Cutaneous Drug Reactions Collection of Clinical Data and Biological Samples
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 1
  • Intervention Type: Drug
  • Participants: 12
  • Start Date: September 6, 2017
Topical Infliximab for the Treatment of Sterile Corneal Melt
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 4
  • Intervention Type: Drug
  • Participants: 10
  • Start Date: July 2016
Evaluation of G-CSF as a Treatment of Toxic Epidermal Necrolysis
Showing 1-10 of 10